AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2579953
Drug: Heparin calcium
RxNorm normalized name: HEPARIN CALCIUM
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin calcium 5000 iu subcutaneously plus dihydroergotamine (DHE) 0.5 mg intramuscularly for 10 days
Trial: 2579953
Drug: Dextran/aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran/aspirin
Trial: 2579953
Drug: DHE/heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHE/heparin
Trial: 31895884
Drug: Lifitegrast ophthalmic
RxNorm normalized name: lifitegrast ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifitegrast ophthalmic solution 5% twice daily for 42 days
Trial: 30396189
Drug: Oral Health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Health Program (OHP)
Trial: 24958410
Drug: Integrated cardiopulmonary
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated cardiopulmonary sonography with standard treatment
Trial: 25417402
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment only (Control)
Trial: 10831103
Drug: 228-ppm-F two-solution
RxNorm normalized name: POUCH,OSTOMY TWO PIECE SYSTEM F#145-0519
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 228-ppm-F two-solution rinse
Trial: 8795596
Drug: Amantadine hydrochloride
RxNorm normalized name: Amantadine Hydrochloride
DrugBank: Amantadine (DB00915)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amantadine hydrochloride (AH; 200 mg daily)
Trial: 1321248
Drug: Lisinopril (5‐40mg/day,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (5‐40mg/day, mean dose 11 mg/day)
Trial: 1321248
Drug: Low-dose trichlormethiazide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose trichlormethiazide (2.0‐4.0 mg/day, mean dose 2.2 mg/day)
Trial: 1321248
Drug: Lisinopril and
RxNorm normalized name: lisinopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril and low-dose trichlormethiazide
Trial: 6427483
Drug: Long-term mitomycin
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term mitomycin C instillation therapy
Trial: 24251381
Drug: Deferiprone (DFP)
RxNorm normalized name: Deferiprone
DrugBank: Deferiprone (DB08826)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Deferiprone (DFP) 30 mg/kg/day
Trial: 22105798
Drug: Carbomer gel
DrugBank: Carbomer (DB15649)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbomer gel
Trial: 17703832
Drug: Intravenous epoetin-delta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous epoetin-delta (ED)
Trial: 11549300
Drug: Modified release
RxNorm normalized name: MODIFIED RELEASE CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified release dipyridamole (200 mg b.i.d. p.o.)
Trial: 9476765
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (FG) injections
Trial: 9476765
Drug: Hypertonic saline-epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline-epinephrine (HSE) injections
Trial: 7946231
Drug: Open-door rehabilitation
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-door rehabilitation treatment
Trial: 7946231
Drug: Standard locked-ward
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard locked-ward treatment
Trial: 29912782
Drug: Cardiac shock-wave
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac shock-wave therapy (CSWT) in addition to optimal medical treatment (OMT)
Trial: 29912782
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy with sham procedure (OMT+placebo)
Trial: 28938905
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg with sustained-release (SR) sarpogrelate 300 mg (Anplone®) once a day for six months
Trial: 28938905
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg with clopidogrel 75 mg once a day for six months
Trial: 24687169
Drug: Metformin hydrochloride
RxNorm normalized name: Metformin Hydrochloride
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin hydrochloride (500 mg) twice daily for 4 months
Trial: 24687169
Drug: Placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo twice daily for 4 months
Trial: 22851564
Drug: Sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (400 mg twice a day) plus gemcitabine (1,250 mg/m² on days 1 and 8) and cisplatin (75 mg/m² on day 1)
Trial: 22851564
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus gemcitabine (1,250 mg/m² on days 1 and 8) and cisplatin (75 mg/m² on day 1)
Trial: 22851564
Drug: Sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (400 mg twice a day)
Trial: 17296390
Drug: Verapamil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (10 mg in 4 cc saline) via electromotive drug administration
Trial: 17296390
Drug: Saline (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (4 cc) via electromotive drug administration
Trial: 9732153
Drug: 3-day oral
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-day oral itraconazole (200 mg daily)
Trial: 9732153
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral fluconazole (150 mg)
Trial: 9732153
Drug: 6-day intravaginal
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-day intravaginal clotrimazole (100 mg daily)
Trial: 12283426
Drug: gemeprost 1
RxNorm normalized name: Gemeprost 1 mg vaginal pessary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemeprost 1 mg pessaries
Trial: 12283426
Drug: PGE2 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 7.5 mg gel
Trial: 6244920
Drug: Captopril (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (150 mg t.i.c.)
Trial: 6244920
Drug: Captopril (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (150 mg t.i.c.) + Hydrochlorothiazide
Trial: 17425493
Drug: Current therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current therapies
Trial: 30389229
Drug: CoQ10 supplementation
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CoQ10 supplementation (400 mg/d)
Trial: 28143495
Drug: Structured SMBG
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured SMBG with additional monthly telecare support from a trained study nurse
Trial: 25929840
Drug: Stepped care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped care intervention package for depression (psychoeducation, activity scheduling, problem solving treatment, and medication for severe depression)
Trial: 17109282
Drug: Intraventricular rt‐PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraventricular rt‐PA treatment
Trial: 7996391
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral doses of (+)-sotalol 50, 100, 200, and 300 mg
Trial: 7996391
Drug: Repeated oral
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated oral doses of (+)-sotalol 200 mg twice daily for 6.5 days
Trial: 7996391
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous doses of (+)-sotalol 1.0 and 1.5 mg kg-1
Trial: 3069682
Drug: Acebutolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (200 mg twice a day)
Trial: 18606983
Drug: Lenalidomide 25
RxNorm normalized name: lenalidomide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 25 mg orally once daily on days 1 to 21, every 28 days, for 52 weeks
Trial: 18606983
Drug: Lenalidomide 25
RxNorm normalized name: lenalidomide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 25 mg orally
Trial: 3354029
Drug: Nimodipine 240
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine 240 mg/day
Trial: 3354029
Drug: Nimodipine 120
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine 120 mg/day
Trial: 31211416
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg of oral vitamin K2
Trial: 31211416
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg of oral vitamin K2
Trial: 31211416
Drug: Both vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vitamin K2 arms (200 μg and 400 μg)
Trial: 22684211
Drug: Lumbar extension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar extension traction in addition to hot packs and interferential therapy
Trial: 22684211
Drug: Hot packs
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot packs and interferential therapy
Trial: 16527405
Drug: 30% l‐menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30% l‐menthol in ethanol
Trial: 14504920
Drug: Irinotecan 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 350 mg/m2 every 21 days (Group A)
Trial: 14504920
Drug: Irinotecan 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 175 mg/m2 days 1 and 10 every 21 days (Group B)
Trial: 12545845
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) treatment at a dose of 0.5 IU/(kg d) subcutaneously between days 3‐17 post‐burn
Trial: 3912616
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + tamoxifen (Group CH)
Trial: 3912616
Drug: Chemotherapy only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy only (Group C)
Trial: 25047263
Drug: Fluorotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorotherapy with sodium fluoride (Elmex fluoride gel® 1.25%) administered once daily for 1 year
Trial: 19674252
Drug: Endothelial antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelial antioxidant compounds (EAC) plus sildenafil (100 mg)
Trial: 19674252
Drug: Sildenafil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (100 mg) alone
Trial: 17652885
Drug: Intensive lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive lipid-lowering therapy (target LDL-C <70 mg/dl)
Trial: 17652885
Drug: Moderate lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate lipid-lowering therapy (target LDL-C <100 mg/dl)
Trial: 7772628
Drug: ranitidine 100
RxNorm normalized name: ranitidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 100 mg twice daily intravenously from the day before operation until the third postoperative day
Trial: 7465140
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g cefamandole
Trial: 26277254
Drug: Physiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy treatment alone (control group)
Trial: 21604490
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg lansoprazole IV infusion
Trial: 21604490
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg lansoprazole IV infusion
Trial: 21604490
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg lansoprazole IV infusion
Trial: 15037271
Drug: Diltiazem (0.05‐0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (0.05‐0.1 mg/kg per hour)
Trial: 9390110
Drug: Nitroglycerin (0.83
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (0.83 mg/hr for 7 days)
Trial: 3283777
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline ('Trental') 3-times daily
Trial: 3283777
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg cinnarizine 3-times daily
Trial: 3283777
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline ('Trental')
Trial: 3283777
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg cinnarizine
Trial: 23565616
Drug: Antiviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral treatment with telbivudine
Trial: 17241768
Drug: Functional voice
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional voice therapy
Trial: 17120738
Drug: Intravenous moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous moxifloxacin 400 mg once a day for 7 to 14 days
Trial: 17120738
Drug: Cefoperazone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone 2.0 g twice a day and azithromycin 0.5 g once a day for 7 to 14 days
Trial: 17120738
Drug: Intravenous moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous moxifloxacin 400 mg once a day
Trial: 17120738
Drug: Cefoperazone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone 2.0 g twice a day and azithromycin 0.5 g once a day
Trial: 10952121
Drug: Platinum/paclitaxel combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum/paclitaxel combination chemotherapy
Trial: 10952121
Drug: Cisplatin/cyclophosphamide combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin/cyclophosphamide combination chemotherapy
Trial: 9085457
Drug: Ethanol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.15 g/kg and 0.45 g/kg)
Trial: 7524382
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with lidocaine (1 mg/kg) combined with moradol (0.005 mg/kg)
Trial: 7524382
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with lidocaine (1 mg/kg) combined with morphine (0.01 mg/kg)
Trial: 20166163
Drug: Radiant infrared
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiant infrared (IR) light emitting diode (LED) (970 nm) pre-treatment for 15 minutes
Trial: 20166163
Drug: Control side
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control side (no IR pre-treatment)
Trial: 20166163
Drug: Radiant IR
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiant IR pre-treatment
Trial: 12423433
Drug: Acitretin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (25 mg daily or on alternate days)
Trial: 10509496
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (n=48)
Trial: 1726521
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid with UVB therapy
Trial: 1726521
Drug: Indifferent ointment
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indifferent ointment (control) with UVB therapy
Trial: 30046129
Drug: Amoxicillin-Clavulanic Acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-Clavulanic Acid
Trial: 9814469
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate (TU) at doses of 40 mg, 20 mg, and 10 mg
Trial: 9814469
Drug: Subcutaneous testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous testosterone implant (100 mg)
Trial: 9814469
Drug: Transdermal delivery
RxNorm normalized name: nitroglycerin 5 mg in 1 d TRANSDERMAL PATCH [Nitroglycerin Transdermal Delivery System]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal delivery system (TD1, TD2, TD3)
Trial: 7662600
Drug: Nicorandil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (20 mg single oral dose)
Trial: 7662600
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) (20 mg single oral dose)
Trial: 7662600
Drug: Nicorandil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (2 x 20 mg/day for 8 days)
Trial: 7662600
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) (3 x 20 mg/day for 8 days)
Trial: 7662600
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) (2 x 20 mg/day for 8 days)
Trial: 2727638
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg bacampicillin
Trial: 2727638
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg amoxycillin
Trial: 2727638
Drug: Omeprazole (potent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (potent acid inhibitor) pretreatment
Trial: 796645
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (1500 mg/day)
Trial: 28720233
Drug: Reflexology (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reflexology (20 min, twice a week for 24 sessions)
Trial: 23619129
Drug: Blood pressure
RxNorm normalized name: Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure (BP) treatment in treated patients (n=16)
Trial: 23619129
Drug: Blood pressure
RxNorm normalized name: Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure (BP) treatment
Trial: 17944981
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied three times a week for 4 weeks
Trial: 9616526
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg prednisolone for 3 weeks
Trial: 31802716
Drug: Intravenous thyroxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thyroxine (T4) infusion for 8 hours
Trial: 31802716
Drug: No T4
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No T4 infusion (control)
Trial: 31802716
Drug: Intravenous thyroxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thyroxine (T4) infusion for 8 hours (in donors with a history of drug use)
Trial: 31802716
Drug: No T4
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No T4 infusion (control) (in donors without a history of drug use)
Trial: 27624670
Drug: Clofarabine 20
RxNorm normalized name: clofarabine 20 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofarabine 20 mg/m2 for 5 days with daunorubicin
Trial: 25098701
Drug: Bevacizumab combination
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab combination therapy
Trial: 19615130
Drug: Continuous high-volume
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous high-volume hemofiltration (HVHF) at 6 L/h for 24 hours
Trial: 19615130
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no HVHF treatment)
Trial: 15614149
Drug: Valganciclovir or
RxNorm normalized name: valganciclovir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir or oral ganciclovir prophylaxis for 100 days
Trial: 2312776
Drug: conventional metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional metoprolol 50 mg tablets
Trial: 23406320
Drug: High-dose intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intradermal (ID) vaccine
Trial: 23406320
Drug: Standard-dose intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose intramuscular (IM) vaccine
Trial: 7995187
Drug: Loperamide treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide treatment
Trial: 26633243
Drug: Self-administered taste
RxNorm normalized name: 60 Second Taste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered taste test using 'Taste Strips' (mean score 12.3 ± 2.6)
Trial: 26633243
Drug: Examiner-administered taste
RxNorm normalized name: 60 Second Taste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Examiner-administered taste test using 'Taste Strips' (mean score 11.6 ± 2.6)